ArticleInternational journal of molecular sciences2017

Lym-1 Chimeric Antigen Receptor T Cells Exhibit Potent Anti-Tumor Effects against B-Cell Lymphoma.

Long Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.